EN
HI
Lupin Chart
Lupin Share Key Metrics
Volume
10.96 L
Market Cap
105357.60 CR
LTQ@LTP
2@2305.20
ATP
2302.05
Var Margin
12.5 %
Circuit Range
2080.3-2542.5
Delivery %
64.45 %
Value
252.19 CR
ASM/GSM
No
Market Lot
1
Summary
Lupin share price stands at ₹2305.2 at 30 Apr, 2026 | 15:55. The stock Lupin intraday movement has stayed between ₹2277.70 and ₹2317.40, while on a 52-week basis it has fluctuated from ₹1836.80 to ₹2381.00.
In terms of trading activity, Lupin has recorded a volume of 1095515 shares. The Lupin has a market cap of ₹457043219. The stock’s Average Traded Price (ATP) stands at ₹230205, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 230520.
The Lupin operates within a circuit range of ₹2080.3-2542.5 – ₹2080.3-2542.5, with a Value of ₹252.19 CR. The Delivery Percentage for the day is 64.45%. Additionally, Lupin currently falls under the No framework, and trades with a market lot size of 1.
Lupin Fundamentals
View MoreP/E Ratio
22.67
P/B Ratio
5.06
Div. Yield
0.52
Sector P/E
65.48
Sector P/B
3.49
Sec. Div. Yield
0.57
Lupin Resistance and Support
Pivot 2300.1
Resistance
First Resistance
2322.5
Second Resistance
2339.8
Third Resistance
2362.2
Support
First Support
2282.8
Second Support
2260.4
Third Support
2243.1
Lupin Futures & Options
Lupin Option Chain
View Price, OI, Greeks & More...
26MAY26
2311.90
1.10 (0.05%)
30JUN26
2322.10
-2.90 (0.12%)
28JUL26
2326.00
0.00 (0.00%)
LUPIN|26MAY26 CE 2300.00
77.10
-0.85 (-1.09%)
LUPIN|26MAY26 PE 2320.00
79.65
2.85 (3.71%)
Lupin Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
Lupin News
Lupin Limited
Lupin Limited's promoter, Manju D. Gupta, and promoter group confirmed no encumbrance on their shares during FY26, in compliance with SEBI SAST Regulations. This declaration covers their total holding of 46.86% of the company's paid-up equity capital.
Apr 28 2026 21:04:00
Lupin Limited
Lupin board will convene on May 7, 2026, to consider audited standalone and cons. financial results for FY26. The meeting will also include a recommendation for a final dividend for the period.
Apr 22 2026 22:04:00
Read More
About Lupin
NSE : 10440
BSE : 500257
ISIN : INE326A01037
Lupin Management
| Name | Position |
|---|---|
| Manju D Gupta | Chairperson |
| Nilesh Gupta | Managing Director |
Lupin Similar Stocks
Divi's Laboratories Ltd.
6502.50
0.00 (0.00%)
Torrent Pharmaceuticals Ltd.
4185.10
0.00 (0.00%)
Dr. Reddy's Laboratories Ltd.
1322.90
0.00 (0.00%)
Apollo Hospitals Enterprise Ltd.
7636.50
0.00 (0.00%)
Cipla Ltd.
1309.60
0.00 (0.00%)
Max Healthcare Institute Ltd.
993.05
0.00 (0.00%)
Mankind Pharma Ltd.
2246.70
0.00 (0.00%)
Zydus Lifesciences Ltd.
891.90
0.00 (0.00%)
Lenskart Solutions Ltd.
515.95
0.00 (0.00%)
Aurobindo Pharma Ltd.
1389.50
0.00 (0.00%)
Lupin FAQs
The Buying Price of Lupin share is 2305.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lupin stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lupin, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lupin shares is 22.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lupin shares is 5.06. Useful to assess the stock's value relative to its book value.
To assess Lupin’s valuation compare Sector P/E, P/B which are 65.48 & 3.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lupin is 105357.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lupin share price is 2381.00 & 1836.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lupin belongs to the Healthcare sector.
